Header Logo

Connection

ANAIS MALPICA to Bevacizumab

Back to Details
This is a "connection" page, showing publications ANAIS MALPICA has written about Bevacizumab.
ANAIS MALPICA
Connection Strength
0.036
Bevacizumab
  1. Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma. Cancer Discov. 2021 11; 11(11):2738-2747.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.